车站3
癌症研究
生物
STAT蛋白
糖蛋白130
体细胞
信号转导
基因
细胞生物学
遗传学
作者
Sandra Rebouissou,Mohamed Amessou,Gabrielle Couchy,Karine Poussin,Sandrine Imbeaud,Camilla Pilati,Tina Izard,Charles Balabaud,Paulette Bioulac‐Sage,Jessica Zucman‐Rossi
出处
期刊:Nature
[Springer Nature]
日期:2008-11-19
卷期号:457 (7226): 200-204
被引量:437
摘要
Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour hepatocytes. Here we show a marked activation of the interleukin (IL)-6 signalling pathway in this tumour type; sequencing candidate genes pinpointed this response to somatic gain-of-function mutations in the IL6ST gene, which encodes the signalling co-receptor gp130. Indeed, 60% of inflammatory hepatocellular adenomas harbour small in-frame deletions that target the binding site of gp130 for IL-6, and expression of four different gp130 mutants in hepatocellular cells activates signal transducer and activator of transcription 3 (STAT3) in the absence of ligand. Furthermore, analysis of hepatocellular carcinomas revealed that rare gp130 alterations are always accompanied by beta-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant conversion of hepatocytes. The recurrent gain-of-function gp130 mutations in these human hepatocellular adenomas fully explains activation of the acute inflammatory phase observed in tumourous hepatocytes, and suggests that similar alterations may occur in other inflammatory epithelial tumours with STAT3 activation.
科研通智能强力驱动
Strongly Powered by AbleSci AI